Ascendant Resources (ASND) Competitors

Acasti Pharma (CVE:ACST) and Ascendant Resources (TSE:ASND) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk.

Does the MarketBeat Community prefer ACST or ASND?

Acasti Pharma received 40 more outperform votes than Ascendant Resources when rated by MarketBeat users. Likewise, 70.53% of users gave Acasti Pharma an outperform vote while only 62.67% of users gave Ascendant Resources an outperform vote.

Company	Underperform	Outperform
Acasti Pharma	Outperform Votes 134 70.53%	Underperform Votes 56 29.47%
Ascendant Resources	Outperform Votes 94 62.67%	Underperform Votes 56 37.33%

Which has more risk & volatility, ACST or ASND?

Acasti Pharma has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500. Comparatively, Ascendant Resources has a beta of 1.57, suggesting that its stock price is 57% more volatile than the S&P 500.

Is ACST or ASND more profitable?

Ascendant Resources' return on equity of 230.96% beat Acasti Pharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Acasti Pharma	N/A	-16.60%	-8.25%
Ascendant Resources	N/A	230.96%	-12.94%

Which has preferable earnings and valuation, ACST or ASND?

Ascendant Resources has higher revenue and earnings than Acasti Pharma. Acasti Pharma is trading at a lower price-to-earnings ratio than Ascendant Resources, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acasti Pharma	C$115K	224.99	-C$17.25M	-C$0.54	-1.07
Ascendant Resources	C$77.82M	0.00	-C$4.75M	-C$0.03	N/A

Do analysts rate ACST or ASND?

Ascendant Resources has a consensus target price of C$0.30, indicating a potential upside of 0.00%. Given Ascendant Resources' higher possible upside, analysts clearly believe Ascendant Resources is more favorable than Acasti Pharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acasti Pharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Ascendant Resources	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Do institutionals & insiders believe in ACST or ASND?

0.1% of Acasti Pharma shares are held by institutional investors. Comparatively, 14.5% of Ascendant Resources shares are held by institutional investors. 20.3% of Acasti Pharma shares are held by company insiders. Comparatively, 3.3% of Ascendant Resources shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Does the media favor ACST or ASND?

In the previous week, Ascendant Resources had 2 more articles in the media than Acasti Pharma. MarketBeat recorded 3 mentions for Ascendant Resources and 1 mentions for Acasti Pharma. Acasti Pharma's average media sentiment score of 0.84 beat Ascendant Resources' score of -0.13 indicating that Acasti Pharma is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Acasti Pharma	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ascendant Resources	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Ascendant Resources beats Acasti Pharma on 8 of the 14 factors compared between the two stocks.